Indication
Multiple Myeloma and Malignant Lymphoma
1 clinical trial
2 products
Clinical trial
A Clinical Trial of KRN125 to Mobilize Hematopoietic Stem Cells Into Peripheral Blood in Patients With Multiple Myeloma and Malignant LymphomaStatus: Completed, Estimated PCD: 2022-10-25
Product
KRN125Product
KRN8601